Case Study
Volume 10 Issue 12 - 2021
Infantile Hypertrophic Pyloric Stenosis in Infancy: A Review Article
Volkan Sarper Erikci*
Professor of Pediatric Surgery, Sağlık Bilimleri University, İzmir Faculty of Medicine, Department of Pediatric Surgery, İzmir Tepecik Health and Research Center, İzmir, Turkey
*Corresponding Author: Volkan Sarper Erikci, Professor of Pediatric Surgery, Sağlık Bilimleri University, İzmir Faculty of Medicine, Department of Pediatric Surgery, İzmir Tepecik Health and Research Center, İzmir, Turkey.
Received: October 08, 2021; Published: November 30, 2021


Infantile hypertrophic pyloric stenosis (IHPS) is the most common cause of nonbilious projectile vomiting in infants. Majority of cases present between 3 - 5 weeks of age and pyloromyotomy introduced by Ramstedt is the definitive treatment. In this review article in addition to historical aspects it is aimed to review the etiology, epidemiology, clinical manifestations and complications of IHPS in children under the light of relevant literature.

Keywords: Infantile Hypertrophic Pyloric Stenosis; Children; Ramstedt’s Pyloromyotomy; Complications


  1. Hirschsprung H. “Falle von angeborener pyloric stenose”. Jahrb Kinderhik 27 (1888): 61.
  2. Aspelund G and Langer JC. “Current management of hypertophic pyloric stenosis”. Seminars in Pediatric Surgery 16 (2007): 27-33.
  3. Cone Thomas. Is Dr. “Patrick Blair’s description of pyloric stenosis in 1717 the earliest on record?” The Journal of Pediatrics 62 (1978): 176.
  4. Ramstedt C. “Zur operation der angeborenen pylorus stenose”. Medizinische Klinik 8 (1912): 1702-1705.
  5. MacKinley G and Barhnart D. “Laparoscopic pyloromyotomy”. In: Bax NMA (edition) Endoscopic Surgery in Infants and Children (2008): 281-286.
  6. To T., et al. “Population demographic indicators associated with incidence of pyloric stenosis”. The Archives of Pediatrics and Adolescent Medicine 159 (2005): 520-525.
  7. Bickler SW. “Incidence of appendicitis and hypertrophic pyloric stenosis in a sub-Saharan African country”. Journal of Pediatric Gastroenterology and Nutrition 31 (2000): S39.
  8. Bickler SW. “Tropical enteropathy protects against Western diseases in environments of poor sanitation”. Medical Hypotheses 67 (2006): 146-150.
  9. Krogh C., et al. “Familial aggregation and heritability of pyloric stenosis”. JAMA: The Journal of the American Medical Association 303 (2010): 2393-2399.
  10. Gibbs MK., et al. “Congenital hypertrophic pyloric stenosis. Surgical experience”. Mayo Clinic Proceedings 50 (1975): 312-316.
  11. Chen EA., et al. “Pyloric stenosis in the age of ultrasonography: fading skills, better patients?” Journal of Pediatric Surgery 31 (1996): 829-830.
  12. Rogers IM. “The enigma of pyloric stenosis. Some thoughts on the aetiology”. Acta Paediatrica 86 (1997): 6-9.
  13. Godbole P., et al. “Ultrasound compared with clinical examination in infantile hypertrophic pyloric stenosis”. Archives of Disease in Childhood 75 (1996): 335-337.
  14. Eberly MD., et al. “Azithromycin in early infancy and pyloric stenosis”. Pediatrics 135 (2015): 483-488.
  15. Krogh C., et al. “Pre- and perinatal risk factors for pyloric stenosis and their influence on the male predominance”. American Journal of Epidemiology 176 (2012): 24-31.
  16. Mandell GA., et al. “Cost-effective imaging approach to the nonbilious vomiting infant”. Pediatrics 103 (1999): 1198202.
  17. McAteer JP., et al. “Role of bottle feeding in the etiology of hypertrophic pyloric stenosis”. JAMA Pediatrics 167 (2013): 1143-1149.
  18. Feenstra B., et al. “Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis”. JAMA: The Journal of the American Medical Association 310 (2013): 714-721.
  19. Feenstra B., et al. “Common variants near MBNL1 and NKX2-4 are associated with infantile hypertrophic pyloric stenosis”. Nature Genetics 44 (2012): 334-337.
  20. Galea R and Said E. “Infantile hypertrophic pyloric stenosis: an epidemiological review”. Neonatal Network4 (2018): 197-204.
  21. Vermes GG., et al. “Maternal factors in the origin of infantile hypertrophic pyloric stenosis- a population-based case-control study”. Congenital Anomalies (2015).
  22. Sevenningsson A., et al. “Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis”. Journal of Pediatric Surgery 49 (2014): 1226-1231.
  23. Block SR., et al. “Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship”. Paediatric and Perinatal Epidemiology 27 (2013): 521-531.
  24. Yau WP., et al. “Use of decongestants during pregnancy and the risk of birth defects”. American Journal of Epidemiology 178 (2013): 198-208.
  25. McAteer JP., et al. “Role of bottle feeding in the etiology of hypertrophic pyloric stenosis”. JAMA Pediatrics 167 (2013): 1143-1149.
  26. Friedman DS., et al. “Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis”. Infection Control and Hospital Epidemiology 25 (2004): 967.
  27. Honein MA., et al. “Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromicin: a case review and cohort study”. Lancet 354 (1999): 2101-2105.
  28. Morrison W. “Infantile hypertrophic pyloric stenosis in infants treated with aziythromicin”. The Pediatric Infectious Disease Journal 26 (2007): 186-188.
  29. Lund M., et al. “Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study”. British Medical Journal 348 (2014): g1908.
  30. Abdellatif M., et al. “Association between eposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis”. European Journal of Pediatrics 178 (2019): 301-304.
  31. Louik C., et al. “Erythromicin use during pregnancy in relation to pyloric stenosis”. American Journal of Obstetrics and Gynecology2 (2002): 288-290.
  32. Kusafuka T and Puri P. “Altered Messenger RNA expression of the neuronal nitric oxide synthase gene in infantile hypertrophic pyloric stenosis”. Pediatric Surgery International 12 (1997): 576-579.
  33. Serra A., et al. “Genomic variants in the coding region of neuronal nitric oxide synthase (NOS1) in infantile hypertrophic pyloric stenosis”. Journal of Pediatric Surgery 46 (2011): 1903-1908.
  34. Modaressi T. “Question of an infectious aetiology or contribution to the pathogenesis of infantile hypertrophic pyloric stenosis”. Journal of Pediatric Gastroenterology and Nutrition 58 (2014): 546-548.
  35. Gotley LM., et al. “Pyloric stenosis: a retrospective study of an Australian population”. Emergency Medicine Australasia5 (2009): 407-413.
  36. White MC., et al. “Sensitivity and cost minimization analysis of radiology versus olive palpation for the diagnosis of hypertrophic pyloric stenosis”. Journal of Pediatric Surgery 33 (1998): 913-917.
  37. Macdessi J and Oates RK. “Clinical diagnosis of pyloric stenosis: a declining art”. British Medical Journal 306 (1993): 553-555.
  38. Shaoul R., et al. “Clinical presentation of pyloric stenosis: the change is in our hands”. The Israel Medical Association Journal (IMAJ) 6 (2004): 134-137.
  39. Lippert MM. “Pyloric stenosis presenting as severe prolonged jaundice. A case report”. South African Medical Journal 69 (1986): 446-447.
  40. Trioche P., et al. “Jaundice with hypertrophic pyloric stenosis as an early manifestation of Gilbert syndrome”. Archives of Disease in Childhood 81 (1999): 301-303.
  41. Hernanz-Schulman M. “Pyloric stenosis: role of imaging”. Pediatric Radiology 39 (2009): S134-S139.
  42. Kofoed PE., et al. “Hypertrophic pyloric stenosis: determination of muscle dimensions by ultrasound”. The British Journal of Radiology 61 (1988): 19-20.
  43. Rohrschneider WK., et al. “Pyloric muscle in symptomatic infants: sonographic evaluation and discrimination from idiopathic hypertrophic pyloric stenosis”. Pediatric Radiology 28 (1998): 429-434.
  44. Hallam D., et al. “Pyloric size in normal infants suspected of having hypertrophic pyloric stenosis”. Acta Radiologica 36 (1995): 261-264.
  45. Aspelund G and Langer JC. “Current management of hypertrophic pyloric stenosis”. Seminars in Pediatric Surgery 16 (2007): 27-33.
  46. Pandya S and Heiss K. “Pyloric stenosis in pediatric surgery: an evidence-based review”. Surgical Clinics of North America 92 (2012): 527-539.
  47. El-Gohary Y., et al. “A 9-year single center experience with circumumbilical Ramstedt’s pyloromyotomy”. European Journal of Pediatric Surgery 20 (2010): 387-390.
  48. Hall NJ., et al. “Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial”. Lancet 373 (2009): 390-398.
  49. Siddiqui S., et al. “Pyloromyotomy: randomized control trial of laparoscopic vs open technique”. Journal of Pediatric Surgery 47 (2012): 93-98.
  50. Hulka F., et al. “Complications of pyloromyotomy for infantile hypertrophic pyloric stenosis”. The American Journal of Surgery 173 (1997): 450-452.
Citation: Volkan Sarper Erikci. “Infantile Hypertrophic Pyloric Stenosis in Infancy: A Review Article”. EC Paediatrics 10.12 (2021): 132-137.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 20, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.